Header Logo

Connection

Kyle Amber to Chemotherapy, Adjuvant

Back to Details
This is a "connection" page, showing publications Kyle Amber has written about Chemotherapy, Adjuvant.
Kyle Amber
Connection Strength
0.037
Chemotherapy, Adjuvant
  1. Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center. J Am Acad Dermatol. 2018 04; 78(4):806-808.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.